期刊文献+

慢性肾脏疾病血管钙化的病因及发病机制 被引量:2

下载PDF
导出
出处 《广东医学》 CAS CSCD 北大核心 2007年第10期1713-1715,共3页 Guangdong Medical Journal
  • 相关文献

参考文献26

  • 1MOE S M, CHEN N X. Pathophysiology of vascular calcification in chronic kidney disease[J]. Circ Res, 2004, 95:560-567.
  • 2SAVAGE T, CLARKE A L, GILES M, et al. Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease[ J]. Nephrol Dial Transplant, 1998, 13:2 004 -2 012.
  • 3BENETOS A, WAEBER R, IZZO J, et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications[J]. AJH, 2002, 15:1 101-1 108.
  • 4GIACHELLI C M, Vascular calcification mechanisms [ J ]. J Am Soc Nephrol, 2004, 15:2 959 -2 964.
  • 5SPEER M Y, GIACHELH C M, Regulation of cardiovascular calcification [ J ]. Cardiovascular Pathology, 2004, 13 : 63 - 70.
  • 6王笑云,陆卫平,赵秀芬.高磷对血管平滑肌细胞骨钙素mRNA表达和钙沉积的影响[J].中华肾脏病杂志,2003,19(2):105-108. 被引量:23
  • 7JONO S, MCKEE M D, MURRY C E, et al. Phosphate regulation of vascular smooth muscle cell calcification [ J]. Circ Res, 2000, 87: 10-17.
  • 8STEITZ S A, SPEER M Y, CURINGA G, et al. Smooth muscle cell phenotypic transition associated with calcification - Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers [J]. Circ Res, 2001, 89:1 147-1 154.
  • 9SPERSCHNEIDER H, GUNTHER K, MARZOLL I, et al. Calcium carbonate( CaCO3 ) : An efficient and safe phosphate binder in haemodialysis patients? A 3 - year study[ J]. Nephrol Dial Transplant, 1993, 8:530-534.
  • 10BLOCK G A, KLASSEN P S, LAZARUS J M, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis [J]. J Am Soc Nephrol, 2004, 15(8) : 2 208 -2 218.

二级参考文献22

  • 1王开 ,钱家麒 ,Peter Stenvinkel ,Bengt Lindholm .终末期肾衰竭患者血清胎球蛋白A水平改变与临床预后的关系[J].中华肾脏病杂志,2005,21(2):72-75. 被引量:21
  • 2Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med, 2000, 342 : 1478-1483.
  • 3Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis:a cross-sectional study. Lancet,2003, 361 (9360) : 827-833.
  • 4US Renal Data System (USRDS):1999 Annual Data Report.Bethesda, National Institute of Diabetes and Kidney Diseases,1999.
  • 5Yokoyama K. Evaluation of coronary artery calcification in ESRD patients. Clin Calcium, 2004, 14:109-115.
  • 6Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium ×phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis, 1998, 31:607-617.
  • 7Levin NW, Hoenich NA. Consequences of hyperphosphatemia and elevated levels of the calcium-phosphorus product in dialysis patients. Curr Opin Nephrol Hypertens, 2001, 10:563 -568.
  • 8Giachelli CM, Jono S, Shioi A, et al. Vascular calcification and inorganic phosphate. Am J Kidney Dis, 2001, 38 (4 Suppl 1 ) : S34-S37.
  • 9Price PA, Lira JE. The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J Biol Chem, 2003, 278 : 22144-22152.
  • 10Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest, 2003,112 : 357-366.

共引文献82

同被引文献42

  • 1陈雯,郭进,马隆佰,颜晓东,陈友华.老年人骨质疏松与冠状动脉钙化的关系[J].中国老年学杂志,2004,24(6):487-489. 被引量:4
  • 2Franklin SS,Gustin W 4th, Wong ND, et aI. Hemodynamic pat- terns of age-related changes in blood pressure. The Framingham heart study[J]. Circulation, 1997,96(1) :308-315.
  • 3Roeha E,Mello e Silva A,Gouveia-Oliveira A,et al. Isolated sys- tolic hypertension epidemiology and impact in clinical practice[J]. Rev Port Cardiol, 2003,22 ( 1 ) : 7-23.
  • 4Benetos A,Thomas F, Bean K, et al. Prognostic value of systolic and diastolic blood pressure in treated hypertension men[J]. Arch Intern Med, 2002,162(5) : 577-581.
  • 5J orde R,Sundsford J, Haug E, et al. Relation between low calcium intake, parathyroid hormone, and blood pressure [ J ]. Hypertension, 2000,35 (5) : 1154-1159.
  • 6Zhao G, Ford ES, Li C,et al. Independent associations of serumconcentrations of 25-hydroxyvitamin D and parathyroid hormone with blood among US adults[J]. J Hypertens,2010,28(9):1821- 1828.
  • 7Snijder MB,Lips P,Seidell JC,et al. Vitamin D status and para- thyroid hormone levels in relation to blood pressure: a population- based study in older men and women[J]. J Intern Med,2007,261 (6) :558-565.
  • 8Jorde R,Svartberg,Sundsfjord J. Serum parathyroid hormone as a predictor of increase in systolic blood pressure in males[J]. J Hy- pertens,2005,23(9) :1639-1644.
  • 9Safar ME. Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors [J]. Curr Opin Nephrol Hypertens, 2001,10(2) : 257-261.
  • 10Harada S, Takeda K. Pulse wave velocity (PWV)[J]. Nippon Rinsho,2004,62(6) :1136-1142.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部